Cargando…
Modulation of mdm2 pre-mRNA splicing by 9-aminoacridine-PNA (peptide nucleic acid) conjugates targeting intron-exon junctions
BACKGROUND: Modulation of pre-mRNA splicing by antisense molecules is a promising mechanism of action for gene therapeutic drugs. In this study, we have examined the potential of peptide nucleic acid (PNA) 9-aminoacridine conjugates to modulate the pre-mRNA splicing of the mdm2 human cancer gene in...
Autores principales: | Shiraishi, Takehiko, Eysturskarð, Jonhard, Nielsen, Peter E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910690/ https://www.ncbi.nlm.nih.gov/pubmed/20591158 http://dx.doi.org/10.1186/1471-2407-10-342 |
Ejemplares similares
-
Editor's note on ‘down-regulation of MDM2 and activation of p53 in human cancer cells by antisense 9-aminoacridine–PNA (peptide nucleic acid) conjugates’
Publicado: (2023) -
Cooperative Cellular Uptake and Activity of Octaarginine Antisense Peptide Nucleic Acid (PNA) Conjugates
por: Ghavami, Mahdi, et al.
Publicado: (2019) -
Subnanomolar antisense activity of phosphonate-peptide nucleic acid (PNA) conjugates delivered by cationic lipids to HeLa cells
por: Shiraishi, Takehiko, et al.
Publicado: (2008) -
The Exon Junction Complex and intron removal prevent re-splicing of mRNA
por: Joseph, Brian, et al.
Publicado: (2021) -
Electroporation Enhanced Effect of Dystrophin Splice Switching PNA Oligomers in Normal and Dystrophic Muscle
por: Brolin, Camilla, et al.
Publicado: (2015)